Abl1m1/Abl1+
involves: 129S/SvEv
|
no abnormal phenotype detected |
J:72519
|
Abl1m1/Abl1m1
B6.129-Abl1m1
|
perinatal lethality, incomplete penetrance |
J:156743
|
Abl1m1/Abl1m1
either: 129S/SvEv-Abl1m1 or (involves: 129S/SvEv * CD-1) or (involves: 129S/SvEv * C57BL/6 * DBA/2)
|
abnormal B cell differentiation |
J:14644
|
abnormal immune system cell morphology |
J:14644
|
abnormal immune system organ morphology |
J:14644
|
abnormal spleen germinal center morphology |
J:14644
|
abnormal spleen morphology |
J:14644
|
abnormal spleen white pulp morphology |
J:14644
|
abnormal T cell number |
J:14644
|
abnormal thymus morphology |
J:14644
|
cataract |
J:14644
|
decreased body weight |
J:14644
|
decreased cranium height |
J:14644
|
decreased immature B cell number |
J:14644
|
decreased pre-B cell number |
J:14644
|
decreased pro-B cell number |
J:14644
|
decreased single-positive T cell number |
J:14644
|
decreased thymocyte number |
J:14644
|
eyelids open at birth |
J:14644
|
increased single-positive T cell number |
J:14644
|
increased susceptibility to infection |
J:14644
|
postnatal lethality, incomplete penetrance |
J:14644
|
premature death |
J:14644
|
spleen hypoplasia |
J:14644
|
thymus cortex hypoplasia |
J:14644
|
thymus hypoplasia |
J:14644
|
Abl1m1/Abl1m1
involves: 129S/SvEv
|
abnormal B cell differentiation |
J:28795
|
abnormal bone marrow cell physiology |
J:28795
|
abnormal immune system cell morphology |
J:34903
|
abnormal splenocyte physiology |
J:34903
|
decreased mature B cell number |
J:28795
|
decreased pre-B cell number |
J:28795
|
decreased pro-B cell number |
J:28795
|
Abl1m1/Abl1m1
involves: 129S/SvEv * C57BL/6
|
abnormal B cell physiology |
J:148105
|
abnormal bone marrow cell physiology |
J:148105
|
abnormal lymphopoiesis |
J:148105
|
decreased pro-B cell number |
J:148105
|
Abl1tm1.1Gcos/Abl1+
involves: 129S1/Sv * 129X1/SvJ
|
abnormal myogenesis |
J:168843
|
decreased physiological sensitivity to xenobiotic |
J:168843
|
Abl1tm1.1Gcos/Abl1tm1.1Gcos
involves: 129S1/Sv * 129X1/SvJ
|
abnormal myogenesis |
J:168843
|
decreased physiological sensitivity to xenobiotic |
J:168843
|
Abl1tm1.1Goff/Abl1tm1.1Goff
involves: C57BL/6
|
no abnormal phenotype detected |
J:156743
|
Abl1tm1Goff/Abl1tm1Goff
involves: C57BL/6
|
abnormal heart ventricle morphology |
J:156743
|
enlarged heart |
J:156743
|
heart hyperplasia |
J:156743
|
perinatal lethality, incomplete penetrance |
J:156743
|
thick ventricular wall |
J:156743
|
Abl1tm1Goff/Abl1tm1Goff Tg(Myh6-cre)2182Mds/0
involves: C57BL/6
|
normal
cardiovascular system phenotype |
J:156743
|
neonatal lethality, complete penetrance |
J:156743
|
thick ventricular wall |
J:156743
|
Abl1tm1Mlg/Abl1tm1Mlg
129S/SvEv-Abl1tm1Mlg
|
postnatal lethality, incomplete penetrance |
J:156743
|
Abl1tm1Mlg/Abl1tm1Mlg
B6.129-Abl1tm1Mlg
|
abnormal heart morphology |
J:156743
|
abnormal heart ventricle morphology |
J:156743
|
abnormal myocardial fiber morphology |
J:156743
|
abnormal myocardium compact layer morphology |
J:156743
|
abnormal trabecula carnea morphology |
J:156743
|
dilated heart atrium |
J:156743
|
enlarged heart |
J:156743
|
heart hyperplasia |
J:156743
|
increased fetal cardiomyocyte proliferation |
J:156743
|
increased heart ventricle size |
J:156743
|
increased heart weight |
J:156743
|
increased myocardial fiber number |
J:156743
|
myocardial fiber disarray |
J:156743
|
neonatal lethality, incomplete penetrance |
J:156743
|
postnatal lethality, incomplete penetrance |
J:156743
|
thick interventricular septum |
J:156743
|
thick ventricular wall |
J:156743
|
Abl1tm1Mlg/Abl1tm1Mlg
involves: 129S/SvEv * C57BL/6J
|
abnormal hepatocyte morphology |
J:72875
|
cachexia |
J:72875
|
normal
cardiovascular system phenotype |
J:156743
|
decreased B cell number |
J:72875
|
decreased lymphocyte cell number |
J:72875
|
decreased survivor rate |
J:72875
|
decreased T cell number |
J:72875
|
decreased thymocyte number |
J:72875
|
enlarged esophagus |
J:72875
|
lung inflammation |
J:72875
|
perinatal lethality, incomplete penetrance |
J:156743
|
postnatal lethality, incomplete penetrance |
J:72875,
J:156743
|
rectal prolapse |
J:72875
|
spleen atrophy |
J:72875
|
thymus atrophy |
J:72875
|
Abl1tm1Mlg/Abl1tm1Mlg
involves: 129S/SvEv * C57BL/6J * CBA
|
abnormal eye morphology |
J:34643
|
abnormal spleen morphology |
J:34643
|
decreased body size |
J:34643
|
decreased bone marrow cell number |
J:34643
|
decreased cranium height |
J:34643
|
decreased survivor rate |
J:34643
|
increased susceptibility to infection |
J:34643
|
postnatal lethality, incomplete penetrance |
J:34643
|
rectal prolapse |
J:34643
|
Abl1tm2.2Goff/Abl1tm2.2Goff
involves: 129P2/OlaHsd * C57BL/6J * FVB/N
|
abnormal cerebellar foliation |
J:166211
|
abnormal cerebellum development |
J:166211
|
decreased body size |
J:166211
|
ectopic cerebellar granule cells |
J:166211
|
neonatal lethality, incomplete penetrance |
J:166211
|
spleen atrophy |
J:166211
|
thymus atrophy |
J:166211
|